Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast...

A comprehensive perspective of trastuzumab-based delivery systems for breast cancer treatment

A Gholami, H Abdouss, M Pourmadadi… - Journal of Drug Delivery …, 2024 - Elsevier
Breast cancer is acknowledged as the second most prominent contributor to cancer-related
fatalities among females. The progression of breast cancer involves several sequential …
被引用次数：3 相关文章

New Concepts in Cardio-Oncology

P Zagami, E Nicolò, C Corti, C Valenza… - Breast Cancer Research …, 2024 - Springer
Cancer and cardiovascular disease are the two major causes of morbidity and mortality in
worldwide. Discovering new therapeutic agents for the management of breast cancer (BC) …
被引用次数：1 相关文章 所有 4 个版本
[PDF] ekb.eg

Cardiotoxic Effect of Adjuvant Subcutaneous versus Intravenous Trastuzumab in HER-2 Positive Breast Cancer

AA Ghany, A Shawky, N Abd El Bary… - The Egyptian Journal …, 2024 - journals.ekb.eg
Background: Another option to intravenous (IV) trastuzumab is subcutaneous (SC)
trastuzumab, which has received approval. There is a lack of information regarding the …
相关文章 所有 3 个版本